Smart Pills and Ingestible Sensors for Real-Time Health Monitoring: A Patient Landscape and Overview
Bibliographic record
Abstract
Abstract: The modern healthcare landscape is intricately linked to the advancement of digital health tools, with digital pills integrated with ingestible sensors representing a transformative innovation. This paper provides a comprehensive analysis of the patent landscape surrounding these digital pills, focusing on trends in patent protection, leading innovators, therapeutic areas of interest, and future prospects. Systems like MyTMed, which include a digital pill with a radiofrequency emitter, a relay hub, and a cloud-based server, demonstrate the potential of digital pills to enhance treatment outcomes by fostering patient compliance, reducing hospital admissions, facilitating mobile clinical monitoring, and lowering treatment costs. A thorough investigation conducted database showed an increase in patent applications concerning ingestible sensor-equipped digital pills. Intelligent medication delivery methods, mobile clinical monitoring, and endoscopic diagnostics are the main areas of innovation. In terms of patent issuance, the US, the EPO, Canada, Australia, and China are in the lead. Mental health, HIV/AIDS, pain management, cardiovascular care, diabetes management, gastroenterology, oncology, TB, and transplantology are important therapeutic fields. Though digital pills have great promise, ethical issues are raised by the focus on income creation and compliance monitoring, raising questions about patient autonomy, privacy, and shared decision-making. To ensure patient rights, more precautions must be taken. This study emphasises the need for strong frameworks for the effective deployment of smart pills and ingestible sensors, pointing out the opportunities and problems in the patent environment. It also signals a trend towards personalised, real-time health monitoring. Patient outcomes and safety are expected to significantly improve with the integration of these technologies into healthcare systems.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame distilled prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.
Codex and Gemma teacher scores by category
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.001 | 0.000 |
| Meta-epidemiology (narrow) | 0.000 | 0.000 |
| Meta-epidemiology (broad) | 0.000 | 0.000 |
| Bibliometrics | 0.000 | 0.001 |
| Science and technology studies | 0.001 | 0.000 |
| Scholarly communication | 0.001 | 0.000 |
| Open science | 0.000 | 0.000 |
| Research integrity | 0.000 | 0.000 |
| Insufficient payload (model declined to judge) | 0.001 | 0.001 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one teacher head, not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".